Home
Market Capitalization of Gland Pharma Ltd

Gland Pharma Ltd
NSE: GLAND
Market Cap
Key Highlights
- The Market Cap of Gland Pharma Ltd is ₹ 30629 crore as of 11 Jul 25 .
- The Latest Trading Price of Gland Pharma Ltd is ₹ 1859 as of 11 Jul 15:30 .
- The Dividend Payouts of Gland Pharma Ltd changed from ₹ 20 on Aug 16, 2024 to ₹ 18 on Aug 14, 2025 . This represents a CAGR of -5.13% over 2 years.

Gland Pharma Ltd
NSE: GLAND
Share Price
Market Price of Gland Pharma Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
11 Jul 2025 | 1859.05 |
10 Jul 2025 | 1842.6 |
09 Jul 2025 | 1878.2 |
08 Jul 2025 | 1887.6 |
07 Jul 2025 | 1875.65 |
04 Jul 2025 | 1873.85 |
03 Jul 2025 | 1874 |
02 Jul 2025 | 1865.85 |
01 Jul 2025 | 1876.7 |
30 Jun 2025 | 1831.95 |
SWOT Analysis Of Gland Pharma Ltd
BlinkX Score for Gland Pharma Ltd
Asset Value vs Market Value of Gland Pharma Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of Gland Pharma Ltd
Historical P/E Ratio of Gland Pharma Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Gland Pharma Ltd
Historical Revenue of Gland Pharma Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Gland Pharma Ltd
Historical EBITDA of Gland Pharma Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Gland Pharma Ltd
Historical Net Profit of Gland Pharma Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Gland Pharma Ltd
Historical Dividend Payouts of Gland Pharma Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payouts of Gland Pharma Ltd
About Gland Pharma Ltd
- Gland Pharma Limited was incorporated as Gland Pharma Private Limited', a private limited company on March 20, 1978 and was granted the certificate of incorporation by Registrar of Companies, Andhra Pradesh at Hyderabad.
- Subsequently, the name of the Company was changed to Gland Pharma Limited' and a fresh certificate of incorporation dated April 25, 1995 was issued by the Registrar of Companies, Andhra Pradesh at Hyderabad.
- The Company is primarily engaged in manufacturing injectable formulations. The company is one of the fastest growing generic injectables-focused companies by revenue in the United States from 2014 to 2019.
- The company has 8 manufacturing facilities in India, comprising four finished formulations facilities with a total of 23 production lines and three API facilities.
Gland Pharma Ltd News Hub
Gland Pharma slides after Q1 PAT slumps 26% YoY to Rs 144 cr
Revenue from operations jumped 15.97% YoY to Rs 1,401.70 crore in Q1 FY25. Profit before tax (PBT) s
Read more
07 Aug 24
Gland Pharma consolidated net profit declines 25.94% in the June 2024 quarter
Net profit of Gland Pharma declined 25.94% to Rs 143.76 crore in the quarter ended June 2024 as agai
Read more
06 Aug 24
US FDA issues 3 Form 483 observations to Gland Pharma's Pashamylaram facility
The said inspection was conducted between 25 July 2024 and 02 August 2024. The said inspection was c
Read more
05 Aug 24
Gland Pharma Ltd gains for third straight session
Gland Pharma Ltd gained for a third straight session today. The stock is quoting at Rs 1936.35, up 1
Read more
09 Sept 24